MATHEWS JOHN: Open Payments
NPI 1174571574 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 38 payments from 14 companies in 2025. Trend: 2023 $518 · 2024 $1,046 · 2025 $1,061
Food & beverage: $956Education: $105
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $221 |
| E.R. Squibb & Sons, L.L.C. | 5 | $155 |
| Supernus Pharmaceuticals, Inc. | 2 | $138 |
| Vanda Pharmaceuticals Inc. | 3 | $96 |
| Alkermes, Inc. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $41 |
| Noven Therapeutics, LLC | 2 | $38 |
Products named: COBENFY, Qelbree, REXULTI, FANAPT, ARISTADA, INGREZZA, AUSTEDO XR, UZEDY.
Industry payments across IN — which companies pay providers there.
